Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%105.161.1%$1271.42m
GILDGilead Sciences, Inc.
0.04%72.850.9%$641.84m
AMGNAmgen Inc.
0.27%170.431.1%$479.27m
REGNRegeneron Pharmaceuticals, Inc.
0.96%391.252.7%$362.53m
BIIBBiogen Inc.
-0.48%308.321.2%$348.13m
ALXNAlexion Pharmaceuticals, Inc.
0.83%108.491.9%$268.85m
VRTXVertex Pharmaceuticals Incorporated
-0.39%146.461.9%$231.81m
ALNYAlnylam Pharmaceuticals, Inc
0.85%133.4510.0%$194.80m
INCYIncyte Corporation
-0.29%98.712.5%$178.72m
NKTRNektar Therapeutics
-3.15%48.196.1%$171.04m
ILMNIllumina, Inc.
-0.07%215.203.5%$154.42m
JUNOJuno Therapeutics, Inc.
1.41%61.1813.5%$139.56m
AAgilent Technologies, Inc.
0.57%69.081.5%$132.41m
SRPTSarepta Therapeutics, Inc.
0.18%56.3216.8%$115.83m
BLUEBluebird Bio, Inc.
0.69%168.3617.2%$115.22m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.